相关实验视频
Updated: Jul 25, 2026

08:12
High-throughput Screening for Protein-based Inheritance in S. cerevisiae
Published on: August 8, 2017
解码SPP1调节:对其在疾病进展中的作用的遗传和非遗传见解
Sungju Jung1, Jiseon Ha1, Jong Hoon Park2
1Laboratory of Biomedical Genomics, Department of Biological Sciences, Sookmyung Women's University, Seoul 04310, Republic of Korea.
Molecules and cells
|April 10, 2025
概括
分泌的蛋白1 (SPP1),或骨质素,对于细胞功能和组织修复至关重要. 它的失调,受遗传和表观遗传因素的影响,驱动诸如癌症和心血管疾病等疾病.
科学领域:
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 分泌蛋白1 (SPP1),也称为骨质素,是一种关键的糖蛋白,参与细胞粘附,免疫反应和组织重塑.
- 最初在骨中被发现,SPP1现在因其在各种组织中的广泛作用及其对健康和疾病的影响而得到认可.
- 异常的SPP1表达与许多疾病的发展和进展有关,包括癌症,心血管疾病,自身免疫疾病和慢性炎症.
研究的目的:
- 提供对控制SPP1表达的遗传和非遗传调节机制的全面审查.
- 检查这些调节机制在各种疾病的发病过程中的影响.
- 通过了解其调节途径,突出SPP1作为生物标志物和治疗点的潜力.
主要方法:
- 文献综述综合了关于SPP1调节和疾病关联的最新发现.
- 在SPP1基因中分析遗传变化 (SNP,indels,结构变异).
- 检查非遗传调节机制,包括DNA甲基化,基因素修饰和长非编码RNAs.
主要成果:
- SPP1的表达受到遗传因素的严格控制,影响疾病的易感性和严重程度,以及对细胞信号作出反应的非遗传因素.
- 在SPP1的遗传变异与增加的风险和改变各种病理的结果有关.
- 表观遗传修饰和非编码RNA显著调节SPP1活动,以响应生理和病理的线索.
结论:
- 遗传倾向和非遗传调节之间的相互作用决定了SPP1活动及其在疾病中的作用.
- 了解SPP1监管网络,可以深入了解疾病机制.
- 专注于SPP1途径的有针对性的干预措施对治疗其起着关键作用的疾病具有前景.
更多相关视频
相关概念视频
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

